Clinical trial
A Prospective, Multicenter, Objective Performance Criteria Study to Evaluate the Efficacy and Safety of an Intracranial Self-expanding Drug Eluting Stent System for Symptomatic Intracranial Atherosclerotic Disease
NCT05217459 is registered in ClinicalTrials.gov with Sinomed Neurovita Technology Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Objective Performance Criteria Study to Evaluate the Efficacy and Safety of an Intracranial Self-expanding Drug Eluting Stent System for Symptomatic Intracranial Atherosclerotic Disease
- Lead sponsor
- Sinomed Neurovita Technology Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 4, 2022
- Completion date
- March 29, 2024
- Enrollment
- 128 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
intracranial arterial diseases, percutaneous transluminal angioplasty, stent restenosis